ASCO 2020: Trastuzumab combined with trimodality treatment does not improve outcomes for patient
Results of the NRG Oncology clinical trial RTOG 1010 indicated that the addition of the…
Browsing: Phase III NRG-RTOG 1010 trial
Trending
- Making Telehealth Human – Podcast
- Sign Up for The Oncology Newsletter | Our free weekly news roundup
- Human pancreatic cancer model offers new opportunities for testing drugs
- Adding ipilimumab to pembrolizumab does not improve efficacy in patients with NSCLC
- Poor brain cancer survival outcomes on the rise
- Oesophageal cancer: 3-D printed stents deliver breakthrough treatment
- Potential therapeutic targets to inhibit colorectal cancer progression
- UK Lockdowns: Significant reduction in new cancer diagnoses
- More than half of cancer survivors have underlying medical conditions associated with severe COVID
- Providing inclusive care for LGBTQ2SPIA cancer patients
